FDA Flags GLP-1 Pens That May Contain No Medication; New Research Published

Related news

1. Oct 2, 2026

   Ozempic / GLP-1 Lawsuits

   FDA Flags GLP-1 Pens That May Contain No Medication; New Research Examines Additional Risks

   According to a report from MedShadow Foundation, the FDA issued a warning that some GLP-1 receptor agonist pens may contain no medication. The report was published alongside separate coverage of ongoing gastroparesis litigation and new peer-reviewed research examining GLP-1 drugs and bipolar disorder hospitalization, pregnancy complications, and orofacial adverse events.

   Source: news.google.com

2. Aug 25, 2026

   Ozempic / GLP-1 Lawsuits

   Search Interest in Ozempic Recalls and Side Effects Surges

   Google Trends data recorded sharp week-over-week increases in searches for terms including "ozempic news" (up 750%), "ozempic news today" (up 950%), "ozempic recall 2025" (up 130%), and "side effects of semaglutide" (up 350%), along with breakout interest in "what is ozempic 2.0." This reflects rising public search activity, not a confirmed regulatory, legal, or court development.

   Source: trends.google.com

3. Aug 24, 2026

   Ozempic / GLP-1 Lawsuits

   Public Search Interest in Ozempic Side Effects and Recalls Rises Sharply

   Google Trends data recorded a sharp week-over-week rise in searches for terms including "ozempic news today" (up 950%), "ozempic news" (up 750%), "ozempic recall 2025" (up 130%), and related side-effect searches such as "common side effects of ozempic" and "side effects of semaglutide" (each up 350%). Several terms, including "what is ozempic 2.0" and "pet food recall news," registered as Google Trends "breakout" searches, indicating unusually large increases in volume.

   Source: trends.google.com